MENU
IXJ
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

IXJ stock forecast, quote, news & analysis

The investment seeks to track the S&P Global 1200 Health Care (Sector) Capped IndexTM... Show more

Category: #Health
IXJ
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for IXJ with price predictions
Sep 11, 2026

IXJ in downward trend: price dove below 50-day moving average on September 08, 2026

IXJ moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend. In 33 of 39 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IXJ moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 26 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IXJ as a result. In 66 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for IXJ turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 37 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in 259 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

IXJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 196 of 255 cases where IXJ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE).

Industry description

The investment seeks to track the S&P Global 1200 Health Care (Sector) Capped IndexTM. The fund seeks to track the investment results of the S&P Global 1200 Health Care (Sector) Capped IndexTM (the “underlying index”), which measures the performance of companies that S&P Dow Jones Indices LLC (the “index provider” or “SPDJI”), a subsidiary of S&P Global, Inc., deems to be a part of the healthcare sector of the economy and that SPDJI believes are important to global markets. The underlying index is a subset of the S&P Global 1200, which is designed to measure the performance of large-capitalization stocks from major global markets, as determined by SPDJI.

Market Cap

The average market capitalization across the iShares Global Healthcare ETF ETF is 94.64B. The market cap for tickers in the group ranges from 64.65K to 994.49B. LLY holds the highest valuation in this group at 994.49B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the iShares Global Healthcare ETF ETF was -4%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was 8%. SIG experienced the highest price growth at 18%, while COO experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the iShares Global Healthcare ETF ETF was 16%. For the same stocks of the ETF, the average monthly volume growth was -2% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 41
P/E Growth Rating: 44
Price Growth Rating: 41
SMR Rating: 58
Profit Risk Rating: 72
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
IXJ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
IXJ in downward trend: price dove below 50-day moving average on September 08, 2026